Novel mutations target distinct subgroups of medulloblastoma
2012 · Nature · 845 citations
https://doi.org/10.1038/nature11213
M
Michael Rusch
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
248
Papers
21.4K
Citations
54
h-index
74
i10-index
Michael Rusch is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Acute Lymphoblastic Leukemia research & Genomics and Rare Diseases. The author has an h-index of 54, co-authored 211 publications.
ORCID: 0000-0002-5363-1848Papers by this author
worksRecurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
2014 · Cell Reports · 735 citations
https://doi.org/10.1016/j.celrep.2014.03.003
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
2016 · Acta Neuropathologica · 394 citations
https://doi.org/10.1007/s00401-016-1539-z
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
2014 · Nature Communications · 387 citations
https://doi.org/10.1038/ncomms4630
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
2019 · Blood · 293 citations
https://doi.org/10.1182/blood.2019002220
Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation
2016 · Scientific Reports · 165 citations
https://doi.org/10.1038/srep25996
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat